Vivos (RDGL) EPS (Basic) Growth (3y) (2013 - 2025)
Vivos (RDGL) EPS (Basic) Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.66 Bn | 175.36 Bn | 6.27 Bn | -6.52% |
| 2 | Stryker | 128.55 Bn | 125.68 Bn | 3.81 Bn | 7.60% |
| 3 | Medtronic | 108.38 Bn | 99.16 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 68.11 Bn | 66.66 Bn | 3.61 Bn | 62.89% |
| 5 | Edwards Lifesciences | 47.19 Bn | 43.52 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.54 Bn | 27.42 Bn | 750.30 Mn | 60.34% |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.09 Bn | 1.98 Bn | 29.37% |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.40 Bn | 2.07 Bn | 30.65% |
| 10 | Vivos | 27.57 Mn | 26.01 Mn | -3,105.00 | -5.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.86% |
| Sep 30, 2025 | -13.08% |
| Jun 30, 2025 | 14.66% |
| Mar 31, 2025 | 2.94% |
| Dec 31, 2024 | -65.90% |
| Sep 30, 2024 | -48.70% |
| Jun 30, 2024 | 39.61% |
| Mar 31, 2024 | -14.36% |
| Dec 31, 2023 | -29.11% |
| Sep 30, 2023 | -46.05% |
| Jun 30, 2023 | -38.71% |
| Mar 31, 2023 | 28.89% |
| Dec 31, 2022 | 11.30% |
| Sep 30, 2022 | 41.02% |
| Jun 30, 2022 | -25.57% |
| Mar 31, 2022 | -125.41% |
| Dec 31, 2021 | -26.19% |
| Sep 30, 2021 | 79.51% |
| Jun 30, 2021 | 56.34% |
| Mar 31, 2021 | 58.64% |